NervGen Pharma Corp.

US$1.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NGENHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 1.11%
Div yield —
ROE (96.84%)
Biotechnology
Beta (5Y) 0.78
PE TTM —
TSR TTM (46.37%)
Mkt cap US$143.0M
ROIC (88.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.50
12.84%
(31.02%)
Sell 12|2|5|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
30.61%
20.64%
13.89%
16.30%
Revenue$M
9.148
9.032
9.251
9.521
5.43%
(0.91%)
2.23%
6.18%
Peers (US$143.0M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.372
0.500
0.435
EBIT/Intx
3.299
0.077
0.083
Own earn%
(20.37)
(76.62)
(90.06)
Sh yield%
44.97
16.52
17.32
Owners
Insiders/Inst%
13.02
42.17
Short interest%
1.68
SBC / revenue%
3.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
23–31
$1 testx
—
Incr. ROIC%
5